Strategic Investment Advisors Novartis Ag Transaction History
Strategic Investment Advisors
- $940 Million
- Q4 2024
A detailed history of Strategic Investment Advisors transactions in Novartis Ag stock. As of the latest transaction made, Strategic Investment Advisors holds 4,679 shares of NVS stock, worth $540,752. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,679
Previous 4,531
3.27%
Holding current value
$540,752
Previous $521,000
12.67%
% of portfolio
0.05%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.27 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$946 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$794 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$645 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...